Viral pneumonia
MONDO:0006012Inflammation of the lung parenchyma that is caused by a viral infection.
Also known as: Viruses caused pneumonia, Viruses pneumonia
88 clinical trials for this condition and its sub-types, 27 tagged with Viral pneumonia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Viral pneumonia
-
Cytomegalovirus pneumonia 0 trials
1 sub-type
-
New inhaled therapy aims to save ventilator patients from viral pneumonia
Disease control Stopped earlyThis study tests an inhaled medicine called SNG001 in patients with severe viral pneumonia who need a breathing machine. The goal is to see if it safely helps clear the virus faster and lowers the risk of death. About 550 adults, mostly over 50 or with weakened immune systems, wi…
Phase 2 • Sponsor: Synairgen Research Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a simple inhaled combo keep pneumonia patients off ventilators?
Disease control Stopped earlyThis phase 3 trial tests whether an inhaled combination of budesonide (a corticosteroid) and formoterol (a bronchodilator) can prevent acute respiratory failure in hospitalized adults with pneumonia and low blood oxygen levels. Participants receive either the active treatment or …
Phase 3 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control Stopped earlyThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Phase 1/2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a simple gas stop COVID-19 from getting worse?
Disease control Stopped earlyThis study tested whether breathing in nitric oxide gas could keep mild-to-moderate COVID-19 from becoming severe. Researchers enrolled 62 hospitalized adults who were breathing on their own. The goal was to see if the gas reduced the need for a breathing tube. The trial was stop…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug aims to keep viral pneumonia patients out of hospital
Disease control Stopped earlyThis Phase 2 trial tested the drug silmitasertib (CX-4945) plus standard care in adults with pneumonia caused by COVID-19 or influenza. The goal was to see if the drug could reduce the need for hospitalization or prevent death. The study planned to enroll 120 people but was termi…
Phase 2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC